Mithra Pharmaceuticals S.A.

MITPFOTCHealthcare

$23.90

+$17.15(+254.07%)

Market Cap$1.6B

P/E Ratio—

52W High$23.9

52W Low$6.75

Avg Volume285.34673

Open$6.75

Beta0.60

Earnings Financials Revenue

Mithra Pharmaceuticals S.A. (MITPF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MITPF · earnings · updated Jun 8, 2026

Latest Earnings

Q1 FY2024Report Date: Mar 8, 2024

EPS Actual

-$1.14

Revenue

$0.02B

Fiscal Period

Q1 FY2024

FY ends December

Report Date

Mar 8, 2024

After Market Close

MITPF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.21

Rev. $0.66B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.21

Rev. Est.$0.66B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2025	May 30, 2025	—	—	—	—	—	—
◌ Q3 FY2024	Sep 26, 2024	—	—	—	—	—	—
◌ Q2 FY2024	May 30, 2024	—	—	—	—	—	—
— Q1 FY2024	Mar 8, 2024	—	-$1.14	—	$0.02B	—	—
— Q4 FY2023	Dec 30, 2023	—	-$1.19	—	$0.04B	—	—
— Q2 FY2023	Jun 29, 2023	—	-$0.96	—	$0.01B	—	—
— Q1 FY2023	Mar 31, 2023	—	-$0.48	—	$0.00B	—	—
— Q1 FY2023	Mar 7, 2023	—	-$0.26	—	$0.03B	—	—

Q2 FY2025

May 30, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 26, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

May 30, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 8, 2024

EPS Actual

-$1.14

EPS Est.

—

EPS Surpr.

—

Revenue

$0.02B

Q4 FY2023

Dec 30, 2023

EPS Actual

-$1.19

EPS Est.

—

EPS Surpr.

—

Revenue

$0.04B

Q2 FY2023

Jun 29, 2023

EPS Actual

-$0.96

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q1 FY2023

Mar 31, 2023

EPS Actual

-$0.48

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2023

Mar 7, 2023

EPS Actual

-$0.26

EPS Est.

—

EPS Surpr.

—

Revenue

$0.03B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2024	Mar 8, 2024	—	$6.75	—	—
— Q4 FY2023	Dec 30, 2023	—	$6.75	—	—
— Q2 FY2023	Jun 29, 2023	—	$6.75	—	—
— Q1 FY2023	Mar 31, 2023	—	$6.75	$6.75	+0.00%
— Q1 FY2023	Mar 7, 2023	—	$6.75	$6.75	+0.00%
— Q4 FY2022	Dec 30, 2022	—	$6.75	$6.75	+0.00%
— Q2 FY2022	Jun 29, 2022	—	$22.70	$22.70	+0.00%

Q1 FY2024—

Report Date

Mar 8, 2024

EPS Beat/Miss

—

Price Before

$6.75

Price After

—

Q4 FY2023—

Report Date

Dec 30, 2023

EPS Beat/Miss

—

Price Before

$6.75

Price After

—

Q2 FY2023—

Report Date

Jun 29, 2023

EPS Beat/Miss

—

Price Before

$6.75

Price After

—

Q1 FY2023+0.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$6.75

Price After

$6.75

Q1 FY2023+0.00%

Report Date

Mar 7, 2023

EPS Beat/Miss

—

Price Before

$6.75

Price After

$6.75

Q4 FY2022+0.00%

Report Date

Dec 30, 2022

EPS Beat/Miss

—

Price Before

$6.75

Price After

$6.75

Q2 FY2022+0.00%

Report Date

Jun 29, 2022

EPS Beat/Miss

—

Price Before

$22.70

Price After

$22.70

Beat Rate0 / 7 quarters

Largest Move+0.00% (Q1 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Mithra Pharmaceuticals S.A. (MITPF) most recently reported earnings on March 8, 2024 for Q1 FY2024, posting EPS of $-1.14 (in line with the analyst consensus of —). The next MITPF earnings date is expected around September 1, 2026.

Each quarter, investors track MITPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MITPF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MITPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MITPF earnings · 4 questions

Mithra Pharmaceuticals S.A.'s next earnings report is expected around September 1, 2026. MITPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MITPF historically reports after market close (AMC).

MITPF earnings datewhen is MITPF earningsMITPF next earnings datewhen does MITPF report earningsMITPF earnings calendar

▸ Source: FMP · Mithra Pharmaceuticals S.A. SEC filings · US GAAP · Mithra Pharmaceuticals S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026